Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and beyond

David Calvin Goff*, Sadiya Sana Khan, Donald Lloyd-Jones, Donna K. Arnett, Mercedes R. Carnethon, Darwin R. Labarthe, Matthew Shane Loop, Russell V. Luepker, Michael V. McConnell, George A. Mensah, Mahasin S. Mujahid, Martin Enrique O'Flaherty, Dorairaj Prabhakaran, Véronique Roger, Wayne D. Rosamond, Stephen Sidney, Gina S. Wei, Janet S. Wright

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

More than 40 years after the 1978 Bethesda Conference on the Declining Mortality from Coronary Heart Disease provided the scientific community with a blueprint for systematic analysis to understand declining rates of coronary heart disease, there are indications the decline has ended or even reversed despite advances in our knowledge about the condition and treatment. Recent data show a more complex situation, with mortality rates for overall cardiovascular disease, including coronary heart disease and stroke, decelerating, whereas those for heart failure are increasing. To mark the 40th anniversary of the Bethesda Conference, the National Heart, Lung, and Blood Institute and the American Heart Association cosponsored the "Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40" symposium. The objective was to examine the immediate and long-term outcomes of the 1978 conference and understand the current environment. Symposium themes included trends and future projections in cardiovascular disease (in the United States and internationally), the evolving obesity and diabetes epidemics, and harnessing emerging and innovative opportunities to preserve and promote cardiovascular health and prevent cardiovascular disease. In addition, participant-led discussion explored the challenges and barriers in promoting cardiovascular health across the lifespan and established a potential framework for observational research and interventions that would begin in early childhood (or ideally in utero). This report summarizes the relevant research, policy, and practice opportunities discussed at the symposium.

Original languageEnglish (US)
Pages (from-to)837-851
Number of pages15
JournalCirculation
Volume143
Issue number8
DOIs
StatePublished - Feb 23 2021

Funding

Dr Labarthe is supported by grant 14SFRN20780002 Trajectories in Ideal Cardiovascular Health from Childhood through Adulthood (July 1, 2014, through June 30, 2021) and grant 17SFRN33660752 Early Life Origins of Cardiovascular Health: Healthier Earlier (July 1, 2017 through June 30, 2021) from the American Heart Association. Dr Loop was supported by ARIC study (Atherosclerosis Risk in Communities), funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract numbers HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HH-SN268201700005I, and HHSN268201700004I.

Keywords

  • cardiovascular diseases
  • health promotion
  • longevity
  • primary prevention
  • trends

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and beyond'. Together they form a unique fingerprint.

Cite this